This effect may be attributed to the triggering of GPX4-associated ferroptotic hepatocyte death, leading to an adaptive immune response characterized by the activation of CD8+ T cells, upregulation of PD-L1 on tumor cells, and infiltration of immunosuppressive MDSCs.322. The gene discussed is GPX4; the disease is neoplasm.